Display options
Share it on

Front Physiol. 2015 Nov 27;6:353. doi: 10.3389/fphys.2015.00353. eCollection 2015.

Prognostic Value of Troponin I for Infarct Size to Improve Preclinical Myocardial Infarction Small Animal Models.

Frontiers in physiology

Aurélien Frobert, Jérémy Valentin, Jean-Luc Magnin, Erwin Riedo, Stéphane Cook, Marie-Noëlle Giraud

Affiliations

  1. Cardiology, Department of Medicine, University and Hospital of Fribourg Fribourg, Switzerland.
  2. Central Laboratory, Hospital Fribourg Fribourg, Switzerland.

PMID: 26640441 PMCID: PMC4661277 DOI: 10.3389/fphys.2015.00353

Abstract

UNLABELLED: Coronary artery ligations to induce myocardial infarction (MI) in mice and rats are widely used in preclinical investigation. However, myocardial ischemic damage and subsequent infarct size are highly variable. The lack of standardization of the model impairs the probability of effective translation to the clinic. Cardiac Troponin I (cTnI) is a major clinically relevant biomarker.

AIM: In the present study, we investigated the prognostic value of cTnI for early estimation of the infarct size.

METHODS AND RESULTS: Infarcts of different sizes were induced in mice and rats by ligation, at a random site, of the coronary artery. Kinetics of the plasma levels of cTnI were measured. Heart function was evaluated by echocardiography, the percentage of infarcted left ventricle and infarct expansion index were assessed from histological section. We observed that plasma cTnI level peaked at 24 h in the infarcted rats and between 24 and 48 h in mice. Sham operated animals had a level of cTnI below 15 ng/mL. Infarct expansion index (EI) assessed 4 weeks after ligation showed a large variation coefficient of 63 and 71% in rats and mice respectively. We showed a significative correlation between cTnI level and the EI demonstrating its predictive value for myocardial injury in small animal models.

CONCLUSION: we demonstrated the importance of cTnI plasma level as a major early marker to assist in the optimal and efficient management of MI in laboratory animals model. The presented results stress the need for comparable biomarkers in the animal model and clinical trials for improved translation.

Keywords: infarct size; myocardial infarction; prognostic value; troponin I

References

  1. Cell Physiol Biochem. 2011;28(1):1-12 - PubMed
  2. Clin Chim Acta. 2002 Nov;325(1-2):87-90 - PubMed
  3. Cardiology. 2012;121(3):204-12 - PubMed
  4. Circ Res. 2012 Jun 22;111(1):131-50 - PubMed
  5. Clin Chem. 2008 Dec;54(12):1982-9 - PubMed
  6. J Appl Physiol (1985). 2007 Jun;102(6):2104-11 - PubMed
  7. Circulation. 2005 Oct 4;112(14):2108-13 - PubMed
  8. CMAJ. 2005 Nov 8;173(10):1191-202 - PubMed
  9. Toxicol Pathol. 2011 Jun;39(4):576-88 - PubMed
  10. Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):11389-94 - PubMed
  11. Toxicol Pathol. 2009 Aug;37(5):617-28 - PubMed
  12. Interface Focus. 2011 Aug 6;1(4):576-601 - PubMed
  13. Am Heart J. 2015 Feb;169(2):257-265.e1 - PubMed
  14. Eur Heart J. 2010 Sep;31(18):2197-204 - PubMed
  15. Toxicol Pathol. 2010 Aug;38(5):703-14 - PubMed
  16. Circulation. 2008 Mar 18;117(11):1388-96 - PubMed
  17. Circ Heart Fail. 2009 Mar;2(2):138-44 - PubMed
  18. Exp Physiol. 2004 Jul;89(4):497-505 - PubMed
  19. Heart Fail Rev. 2013 Mar;18(2):219-49 - PubMed
  20. Acta Biomater. 2014 Jul;10(7):2996-3006 - PubMed
  21. Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H1765-80 - PubMed
  22. Lab Anim. 2006 Apr;40(2):153-71 - PubMed
  23. J Am Coll Cardiol. 2004 Jun 16;43(12 ):2253-9 - PubMed
  24. J Vis Exp. 2014 Sep 22;(91):51390 - PubMed
  25. Life Sci. 2013 Aug 6;93(4):139-44 - PubMed

Publication Types